Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Cybin

Data updated

Canada
6 Trials

Cybin Inc. (founded 2019) is a Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapeutics—now operating as Helus Pharma—focused on proprietary novel serotonergic agonists and deuterated psilocin analogs for mental health conditions.

ProfessionalOnlineFreeFacilitation trainingContinuing educationOtherAspiring practitionersLicensed cliniciansFacilitatorsOther

Blossom’s read

Cybin, now operating as Helus Pharma, looks less like a conventional training school and more like a biotech company that built an open-access facilitator course around its clinical programme. The strongest fit is clinicians or psychologically oriented professionals who want an evidence-led introduction to psychedelic support within a trial and future prescribing context, rather than a broad, practitioner-brand course. Its reputation reads as science-first and fairly credible, with notable lineage in established psychedelic training circles, though the training is clearly tied to the company’s own pipeline and not an independent credentialing body.

Who Cybin is for

Best suited to healthcare professionals, therapists, and people interested in offering psychological support who want a structured introduction to psychedelic facilitation. It is less obviously aimed at the curious public and more at those moving towards clinical or trial-adjacent work.

Prerequisites

The sources support that EMBARK OA is open online and aimed at healthcare professionals and people interested in offering psychological support. For the broader EMBARKCT programme, the company says it is a facilitation training programme and a bridge for facilitators into future EMBARK training and possible company-sponsored clinical trials, but I could not verify formal entry requirements from the sources reviewed.

Accreditation & recognition

I could not verify formal accreditation, CME/CE credit, or an externally recognised certification from the sources reviewed. Cybin describes EMBARK OA as a free open online course and EMBARK as a training model, but the public sources I found do not clearly state accredited status.

Cost

EMBARK Open Access is described by Cybin as free. I did not find a reliable public tuition figure for EMBARKCT or any clear inclusion list beyond the course itself and training modules.

What you walk away with

Learners appear to gain a transdiagnostic framework for psychedelic facilitation, including the six EMBARK clinical domains, trauma-informed and culturally competent principles, and guidance for supporting participants safely and effectively through sessions. The practical pathway seems to be skill-building and, for some, preparation for future EMBARK training or potential participation in Cybin-sponsored clinical trials.

Similar course providers

Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.

BrainFutures
  • Strong match: 2 shared modalities
  • Strong match: 2 shared learner audiences
  • Also shares: professional level
  • Also shares: online delivery
Alchemy
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: online delivery
Psychedelic Medicine Association
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: online delivery
Psychedelic Support
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: online delivery

Quick Facts

Type
biotech
Founded
2019
HQ
Canada
Website
Visit

Sponsored Trials

6